Articles by " Jeff Stewart"
BMY “Consents” to Improper Orange Book Listings
March 7, 2003 The Federal Trade Commission today announced that Bristol-Myers Squibb Company (Bristol) – one of the world’s largest [...]
AAI’s Prosac & Prilosec Patents & Buspar Delisting
July 18, 2001 I – AAI’s Prilosec patents AAI may have something. They apparently have identified that Prilosec is a [...]
Adderal XR Claims Construction: Shire, Impax & Barr
Introduction Barr and Impax seek to launch generic versions of Shire Lab’s ADHD drug Adderal XR®. Shire sued Barr in [...]
Adderall XR: Shire Shares Rise on Settlement With Barr
Bloomberg By Etain Lavelle – Aug 15, 2006 Shire Plc shares rose after the company settled a patent lawsuit with [...]
ADM: European Commission investigates ADM
June 30, 1997 On June 12, 1997, ADM announced that the European Commission is conducting an antitrust investigation of it. [...]
ADM: How Long will investigation cripple management?
July 25, 1995 Testimony, subpoenas and search warrants have been issued by a Chicago grand jury investigating Archer Daniels Midland [...]
ADM: Judge to Dismiss Lawsuit after 6 years
July 16, 2001 A federal judge here said he plans to dismiss a six-year- old class-action lawsuit that accuses Archer-Daniels-Midland [...]
ADM’s Antitrust War Sputters Toward Conclusion
September 30, 1996 On July 25, 1995 in its first report on ADM’s antitrust woes, Verdict stated: “The Justice Department [...]
AHP 1: Stock rise ignores the fen-phen litigation
May 30,1998 Introduction: After American Home Products withdrew Redux and Pondimin from the market last September, the stock fell. In [...]
AHP 2: Punitive damages awarded in Diet Drug Cases
A summary of four earlier Verdict reports show that AHP had repeatedly underestimated reserves for fen-phen.
Related Case Type
